Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Eur Ann Allergy Clin Immunol ; 53(6): 280-283, 2021 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-33728833

RESUMEN

SUMMARY: Topical treatments in ophthalmologic therapy are significant for the development of allergic contact dermatitis (ACD) in the periorbital region. Preservatives, antibiotics, glucocorticoids, and beta-blocker eye drops are defined as drugs with the highest sensitizing potential. The unavailability of patch test batteries containing substances of ophthalmological use makes it difficult for this diagnosis. In the present report, we describe six patients who developed ACD induced by different agents presenting in eye drops, confirmed with the cutaneous patch tests. The ACD diagnosis due to ophthalmic medications can be challenging, since many different agents can cause it, and the sensitivity of these cutaneous tests is low. Thus, early diagnosis is essential to avoid the complications of ACD on the skin and ocular disorders related to chronic periorbital eczema.


Asunto(s)
Dermatitis Alérgica por Contacto , Dermatología , Brasil , Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Alérgica por Contacto/etiología , Humanos , Soluciones Oftálmicas/efectos adversos , Pruebas del Parche
2.
Clin Transl Oncol ; 21(5): 621-629, 2019 May.
Artículo en Inglés | MEDLINE | ID: mdl-30341474

RESUMEN

PURPOSE: The third most frequently diagnosed cancer in Europe in 2018 was lung cancer; it is also the leading cause of cancer death in Europe. We studied patient and tumor characteristics, and patterns of healthcare provision explaining regional variability in lung cancer survival in southern Spain. METHODS: A population-based cohort study included all 1196 incident first invasive primary lung cancer (C33-C34 according to ICD-10) cases diagnosed between 2010 and 2011 with follow-up until April 2015. Data were drawn from local population-based cancer registries and patients' hospital medical records from all public and private hospitals from two regions in southern Spain. RESULTS: There was evidence of regional differences in lung cancer late diagnosis (58% stage IV in Granada vs. 65% in Huelva, p value < 0.001). Among patients with stage I, only 67% received surgery compared with 0.6% of patients with stage IV. Patients treated with a combination of radiotherapy, chemotherapy, and surgery had a 2-year mortality risk reduction of 94% compared with patients who did not receive any treatment (excess mortality risk 0.06; 95% CI 0.02-0.16). Geographical differences in survival were observed between the two regions: 35% vs. 26% at 1-year since diagnosis. CONCLUSIONS: The observed geographic differences in survival between regions are due in part to the late cancer diagnosis which determines the use of less effective therapeutic options. Results from our study justify the need for promoting lung cancer early detection strategies and the harmonization of the best practice in lung cancer management and treatment.


Asunto(s)
Detección Precoz del Cáncer/mortalidad , Servicios de Salud , Disparidades en Atención de Salud , Neoplasias Pulmonares/mortalidad , Sistema de Registros/estadística & datos numéricos , Adolescente , Adulto , Anciano , Estudios de Cohortes , Terapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Neoplasias Pulmonares/epidemiología , Neoplasias Pulmonares/patología , Neoplasias Pulmonares/terapia , Masculino , Persona de Mediana Edad , Pronóstico , Factores de Riesgo , España/epidemiología , Tasa de Supervivencia , Adulto Joven
3.
Rev Inst Med Trop Sao Paulo ; 35(4): 373-5, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8115799

RESUMEN

A 15 year old male patient was diagnosed as being infected with the nematode Lagochilascaris minor, presenting as abscesses over the left mastoid region, and invading the temporal bone, mastoid sinuses and possibly the CNS. Surgical drainage and administration of cambendazole and levamisole led to improvement, followed by an early relapse and poor tolerance to the antihelminthic drugs. Repeated doses of ivermectin (an animal preparation) were used for the first time to treat this condition and resulted in complete remission of signs of infection, maintained for 15 months after the end of drug therapy, indicating cure of the disease.


Asunto(s)
Antibacterianos , Ascaridiasis/tratamiento farmacológico , Quimioterapia Combinada/uso terapéutico , Adolescente , Animales , Ascaridia/aislamiento & purificación , Cambendazol/administración & dosificación , Drenaje , Humanos , Ivermectina/administración & dosificación , Levamisol/administración & dosificación , Masculino
4.
Can J Microbiol ; 26(9): 1126-31, 1980 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-6257362

RESUMEN

Production of H2 by Azospirillum brasilense under N2-fixing conditions was studied in continuous and batch cultures. Net H2 production was consistently observed only when the gas phase contained CO. Nitrogenase activity (C2H2 reduction) and H2 evolution (in the presence of 5% CO) showed a similar response to O2 and were highest at 0.75% dissolved O2. Uptake hydrogenase activity, ranging from 0.3 to 2.5 mumol H2/mg protein per hour was observed in batch cultures under N2. Such rates were more than sufficient to recycle nitrogenase-produced H2. Tritium-exchange assay showed that H2 uptake was higher under Ar than under N2. Uptake hydrogenase was strongly inhibited by CO and C2H2. Cyclic GMP inhibited both nitrogenase and uptake hydrogenase activities.


Asunto(s)
Bacterias/metabolismo , Hidrógeno/metabolismo , Acetileno/metabolismo , Monóxido de Carbono/farmacología , Medios de Cultivo , GMP Cíclico/farmacología , Hidrogenasas , Nitrógeno/metabolismo , Oxidorreductasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA